000 01108 a2200289 4500
005 20250513033759.0
264 0 _c19950810
008 199508s 0 0 eng d
022 _a0065-1591
024 7 _a10.1111/j.1600-0447.1995.tb05941.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFleischhacker, W W
245 0 0 _aNew drugs for the treatment of schizophrenic patients.
_h[electronic resource]
260 _bActa psychiatrica Scandinavica. Supplementum
_c1995
300 _a24-30 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAffective Symptoms
_xclassification
650 0 4 _aAntipsychotic Agents
_xadverse effects
650 0 4 _aBrain
_xdrug effects
650 0 4 _aHumans
650 0 4 _aPsychiatric Status Rating Scales
650 0 4 _aReceptors, Neurotransmitter
_xdrug effects
650 0 4 _aSchizophrenia
_xclassification
650 0 4 _aSchizophrenic Psychology
773 0 _tActa psychiatrica Scandinavica. Supplementum
_gvol. 388
_gp. 24-30
856 4 0 _uhttps://doi.org/10.1111/j.1600-0447.1995.tb05941.x
_zAvailable from publisher's website
999 _c7604174
_d7604174